SEC Filings for Anika Therapeutics Inc. (ANIK)

$ 35.39   1.21 (+3.54%) Volume: 167.18k 4:00 PM EDT 30-Sep-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)409/08/2020
3Initial statement of beneficial ownership of securities109/08/2020
3Initial statement of beneficial ownership of securities109/08/2020
4Statement of changes in beneficial ownership of securities109/08/2020
4Statement of changes in beneficial ownership of securities109/08/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals108/17/2020
4Statement of changes in beneficial ownership of securities108/12/2020
3Initial statement of beneficial ownership of securities108/12/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)408/07/2020
10-Q/A[Amend] Quarterly report [Sections 13 or 15(d)]608/06/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals108/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)908/05/2020
8-KCurrent report pursuant to Section 13 or 15(d)407/30/2020
4Statement of changes in beneficial ownership of securities107/10/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans506/19/2020
<<
First
<
Prev
123456789101112131415